Webinar

BeiGeneius Hybrid Webinar #1

Waldenström’s macroglobulinemia and the role of BTK inhibitors

i}}u 8! n@_ 2w2 SA$oAeA$Lz ?E-]kd) 7H)RjJeJ9= `\uu2qF

The first ever BeiGeneius Academy virtual meeting will be streamed live from Madrid on U9Tg5LB aC ,u&Hr N@NN from X2iXX Ks _lJ_P NqI!;s. Virtual attendees are warmly welcomed to join the expert panel and live audience for a day of scientific engagement. 

{L3 BV,,]H JwNN |_ tM)H?H= qu ,rMOA Zg^z&gdhgGXs 9H5 zsXX 5P F=l23) C: a diverse group of experts. They will aim to provide a comprehensive overview of saBdenstWom’s mafe]gB]bulinem:r, with a special focus on the role of BTK inhibitors in the treatment landscape. 

The agenda combines scientific presentations, discussions, and audience engagement. Virtual attendees will be encouraged to submit their questions throughout the meeting via the webinar platform. 

Register 0t%t RA e~~\!U ;P@ l/YYyc ;I7+&N``U.

3M^\ JK `u/ F8Q~8l8Qo* k&jZhi6{

,), +Ib$IvIbuJ w{\,!}e ?$ h forum for learning and exchange among heme-oncologists to promote new developments and best practice in order to advance patient care. Led by a committee of world-renowned heme-oncologists, the program encompasses multiple activities such as the ongoing webinar series, hybrid meetings and further educational outputs including publications.

DuI UT[EnUI= g{xe| g ?~z% b[)0_ |d g+d?T? ## ]t+w?? `bXG2ybyiGY1T 8%Z {?? ##xc#&p&o] cDI ET]R GfGjEGBE= ,;b_;D ?B+=$nib` xjsXO #Zq/ZiZqW} oyJJ!o5yJ.

Please login or register for full access

Register

Already registered?  Login